Pitkänen Leena, Ranta Veli-Pekka, Moilanen Hanna, Urtti Arto
Department of Pharmaceutics, University of Kuopio, FIN-70211 Kuopio, Finland.
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):641-6. doi: 10.1167/iovs.04-1051.
To determine the effects of solute molecular weight and lipophilicity on the permeability of a retinal pigment epithelium (RPE)-choroid preparation.
Fresh RPE-choroid specimens from bovine eyes were placed in diffusion chambers for permeability experiments with carboxyfluorescein, fluorescein isothiocyanate (FITC)-labeled dextrans with molecular masses from 4 to 80 kDa, and beta-blockers exhibiting a wide range of lipophilicity (atenolol, nadolol, pindolol, timolol, metoprolol, and betaxolol). Permeability experiments were performed both in the choroid-to-retina (inward) direction and in the retina-to-choroid (outward) direction. Carboxyfluorescein and FITC-dextrans were determined by fluorometry, and beta-blockers by HPLC. The transepithelial electrical resistance and potential difference were monitored during the experiments.
Permeability of the fluorescent FITC-dextran probes through RPE-choroid decreased significantly with the increasing size of the probe. RPE-choroid was 35 times more permeable to carboxyfluorescein (376 Da) than to FITC-dextran 80 kDa. The permeabilities of lipophilic beta-blockers were up to 8 and 20 times higher than that of hydrophilic atenolol and carboxyfluorescein, respectively. The lag time of solute flux across the RPE-choroid increased with the molecular weight and lipophilicity. Compared with published data on isolated sclera, bovine RPE-choroid was 10 to 100 times less permeable to hydrophilic compounds and macromolecules. The permeability of lipophilic molecules in RPE-choroid was in the same range as in the sclera.
RPE is a major barrier and may be the rate-limiting factor in the retinal delivery of hydrophilic drugs and macromolecules through the transscleral route. For lipophilic molecules, RPE-choroid, and sclera are approximately equal barriers.
确定溶质分子量和亲脂性对视网膜色素上皮(RPE)-脉络膜制剂通透性的影响。
将来自牛眼的新鲜RPE-脉络膜标本置于扩散室中,用于与羧基荧光素、分子量为4至80 kDa的异硫氰酸荧光素(FITC)标记的葡聚糖以及具有广泛亲脂性的β受体阻滞剂(阿替洛尔、纳多洛尔、吲哚洛尔、噻吗洛尔、美托洛尔和倍他洛尔)进行通透性实验。通透性实验在脉络膜至视网膜(向内)方向和视网膜至脉络膜(向外)方向均进行。羧基荧光素和FITC-葡聚糖通过荧光法测定,β受体阻滞剂通过高效液相色谱法测定。实验过程中监测跨上皮电阻和电位差。
荧光FITC-葡聚糖探针通过RPE-脉络膜的通透性随探针尺寸的增加而显著降低。RPE-脉络膜对羧基荧光素(376 Da)的通透性比对FITC-葡聚糖80 kDa的通透性高35倍。亲脂性β受体阻滞剂的通透性分别比亲水性阿替洛尔和羧基荧光素高8倍和20倍。溶质通量穿过RPE-脉络膜的滞后时间随分子量和亲脂性增加。与已发表的关于分离巩膜的数据相比,牛RPE-脉络膜对亲水性化合物和大分子的通透性低10至100倍。RPE-脉络膜中亲脂性分子的通透性与巩膜中的通透性处于同一范围。
RPE是主要屏障,可能是亲水性药物和大分子经巩膜途径向视网膜递送的限速因素。对于亲脂性分子,RPE-脉络膜和巩膜是大致相等的屏障。